Literature DB >> 14499573

Study of the inhibition of four alpha amylases by acarbose and its 4IV-alpha-maltohexaosyl and 4IV-alpha-maltododecaosyl analogues.

Seung-Heon Yoon1, John F Robyt.   

Abstract

Acarbose analogues, 4IV-maltohexaosyl acarbose (G6-Aca) and 4IV-maltododecaosyl acarbose (G12-Aca), were prepared by the reaction of cyclomaltodextrin glucanyltransferase with cyclomaltohexaose and acarbose. The inhibition kinetics of acarbose and the two acarbose analogues were studied for four different alpha-amylases: Aspergillus oryzae, Bacillus amyloliquefaciens, human salivary, and porcine pancreatic alpha-amylases. The three inhibitors showed mixed, noncompetitive inhibition, for all four alpha-amylases. The acarbose inhibition constants, Ki, for the four alpha-amylases were 270, 13, 1.27, and 0.80 microM, respectively; the Ki values for G6-Aca were 33, 37, 14, and 7 nM, respectively; and the G12-Aca Ki constants were 59, 81, 18, and 11 nM, respectively. The G6-Aca and G12-Aca analogues are the most potent alpha-amylase inhibitors observed, with Ki values one to three orders of magnitude more potent than acarbose, which itself was one to three orders of magnitude more potent than other known alpha-amylase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499573     DOI: 10.1016/s0008-6215(03)00293-3

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  8 in total

1.  Inhibitory effects of Rosa gallica on the digestive enzymes.

Authors:  Sarangowa Ochir; Makoto Nishizawa; Byoung Jae Park; Kouta Ishii; Tsutomu Kanazawa; Minoru Funaki; Takashi Yamagishi
Journal:  J Nat Med       Date:  2010-03-16       Impact factor: 2.343

2.  Amylomaltase of Pyrobaculum aerophilum IM2 produces thermoreversible starch gels.

Authors:  Thijs Kaper; Boguslawa Talik; Thijs J Ettema; Herman Bos; Marc J E C van der Maarel; Lubbert Dijkhuizen
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

3.  Inhibition of Porcine Pancreatic Amylase Activity by Sulfamethoxazole: Structural and Functional Aspect.

Authors:  Sujan Maity; Koel Mukherjee; Amrita Banerjee; Suman Mukherjee; Dipak Dasgupta; Suvroma Gupta
Journal:  Protein J       Date:  2016-06       Impact factor: 2.371

4.  Templating α-amylase peptide inhibitors with organotin compounds.

Authors:  Fernando Porcelli; Cristina Olivieri; Larry R Masterson; Yi Wang; Gianluigi Veglia
Journal:  J Biol Inorg Chem       Date:  2011-07-07       Impact factor: 3.358

5.  The human microbiome encodes resistance to the antidiabetic drug acarbose.

Authors:  Jared Balaich; Michael Estrella; Guojun Wu; Philip D Jeffrey; Abhishek Biswas; Liping Zhao; Alexei Korennykh; Mohamed S Donia
Journal:  Nature       Date:  2021-11-24       Impact factor: 69.504

6.  Evaluation of a flavonoids library for inhibition of pancreatic α-amylase towards a structure-activity relationship.

Authors:  Carina Proença; Marisa Freitas; Daniela Ribeiro; Sara M Tomé; Eduardo F T Oliveira; Matilde F Viegas; Alberto N Araújo; Maria J Ramos; Artur M S Silva; Pedro A Fernandes; Eduarda Fernandes
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

7.  Acylated Aminooligosaccharides with Inhibitory Effects against α-Amylase from Streptomyces sp. HO1518.

Authors:  Hai-Li Liu; Heng-Chao E; Ding-An Xie; Wen-Bo Cheng; Wan-Qi Tao; Yong Wang
Journal:  Mar Drugs       Date:  2018-10-23       Impact factor: 5.118

8.  Magnificamide, a β-Defensin-Like Peptide from the Mucus of the Sea Anemone Heteractis magnifica, Is a Strong Inhibitor of Mammalian α-Amylases.

Authors:  Oksana Sintsova; Irina Gladkikh; Aleksandr Kalinovskii; Elena Zelepuga; Margarita Monastyrnaya; Natalia Kim; Lyudmila Shevchenko; Steve Peigneur; Jan Tytgat; Emma Kozlovskaya; Elena Leychenko
Journal:  Mar Drugs       Date:  2019-09-21       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.